Network pharmacology reveals the potential molecular mechanisms of Polygonatum sibiricum in the treatment of sleep disorders
New Discovery · 18.03.2026
DOI: 10.61958/ndqg5111 ↗Kurz gefasst
Fachartikel in der Zeitschrift New Discovery, online erschienen am 18.03.2026. Verfasst von Zhao-Hong Wei und 2 weiteren Autor:innen. Die Arbeit nennt 44 Literaturangaben.
Abstract (Originalsprache)
Background
Sleep disorders are multifactorial conditions involving complex physiological dysregulation. Despite the widespread traditional use of Polygonatum sibiricum (P. sibiricum) for health enhancement, its potential therapeutic effects on sleep disorders remain insufficiently characterized. To address this gap, the present study employed a network pharmacology approach to elucidate the molecular mechanisms through which P. sibiricum may exert anti–sleep disorder effects.
Methods
We initially conducted a comprehensive screening using TCMSP, Herb, and GeneCards. Venn analysis was employed to identify intersections between the active components of P. sibiricum and sleep disorder-related genes, yielding 114 core intersection targets. A protein interaction (PPI) network was constructed using the STRING database, and core genes were identified through Cytoscape software. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were conducted to elucidate the biological functions, signaling pathways, and potential mechanistic roles of these core genes in mediating the therapeutic effects of P. sibiricum on sleep disorders.
Results
A total of 2,076 sleep disorder-related targets and 243 P. sibiricum-related targets were retrieved. Cross-analysis revealed 10 core genes, including caspase 3 (CASP3), epidermal growth factor receptor (EGFR), mechanistic target of rapamycin (MTOR), hypoxia inducible factor 1 subunit alpha (HIF1A), AKT serine/threonine kinase 1 (AKT1), caspase 8 (CASP8), tumor necrosis factor (TNF), Jun proto-oncogene (JUN), BCL2 apoptosis regulator (BCL2), and estrogen receptor 1 (ESR1). GO enrichment analysis indicated that these genes primarily regulate chemotaxis, modulate cellular responses to growth factors via MAPK3 and EGFR, participate in neural repair and inflammatory homeostasis, and influence neurological function and inflammation through endoplasmic reticulum stress and membrane signaling. They may also affect hemoglobin-binding capacity to regulate oxidative stress and inflammation, suggesting a novel mechanistic pathway. KEGG analysis further highlighted the central role of TNF-mediated inflammatory signaling and the enrichment of tumor-related pathways due to their shared inflammatory and cellular stress mechanisms.
Conclusions
P. sibiricum may improve sleep disorders through a multitarget, multipathway mechanism. Its active components regulate core genes such as CASP3, EGFR, and HIF1A, thereby modulating inflammatory microenvironment, neural functions, and oxidative stress-related pathways.
Zitieren
APA
Wei, Z., Liao, Y., & Zhuo, K. (2026). Network pharmacology reveals the potential molecular mechanisms of Polygonatum sibiricum in the treatment of sleep disorders. New Discovery. https://doi.org/10.61958/ndqg5111
Vancouver
Wei Z, Liao Y, Zhuo K. Network pharmacology reveals the potential molecular mechanisms of Polygonatum sibiricum in the treatment of sleep disorders. New Discovery. 2026. doi:10.61958/ndqg5111
BibTeX
@article{Wei2026,
author = {Wei, Zhao-Hong and Liao, Yu-Feng and Zhuo, Ke-Yu},
title = {Network pharmacology reveals the potential molecular mechanisms of Polygonatum sibiricum in the treatment of sleep disorders},
journal = {New Discovery},
year = {2026},
doi = {10.61958/ndqg5111}
}
EUVIMED